Drugs (ISSN 0012-6667) is a highly respected international journal in the field of pharmacology and therapeutics, published by Adis International Ltd based in New Zealand. Operating on a semi-monthly schedule, this non-open access publication is indexed in the Science Citation Index (SCI) and consistently maintains a high impact factor, placing it within the top quartile of medical and pharmaceutical sciences according to the Chinese Academy of Sciences journal rankings. The journal focuses on critical areas such as drug development, clinical pharmacology, therapeutics, and pharmacoeconomics, with a particular emphasis on the clinical evaluation of innovative medicines and the promotion of rational drug use. Known for publishing high-quality review articles and original research, Drugs serves as a valuable resource for researchers and clinicians engaged in pharmaceutical science and medical practice. While the journal is noted for its rigorous peer-review process, which may result in longer review times, and requires subscription for full-text access, it remains a leading authority in the field, offering scholars a prestigious platform for disseminating impactful findings in drug research and clinical application.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com